Dr. Reddy’s Laboratories launches Venlafaxine ER Tablets in US
Dr. Reddy’s Laboratories said that it has launched Venlafaxine ER Tablets, which is therapeutically equivalent to Osmotica Pharmaceutical US’ Venlafaxine Extended-Release Tablets, 150 mg and ... Read More
Dr. Reddy’s Laboratories launches ephedrine sulfate injection generic in US
Dr. Reddy’s Laboratories has launched Ephedrine Sulfate Injection USP, 50 mg/mL, a generic version of Exela Sterile Medicines’ hypotension drug Akovaz (ephedrine sulfate injection) Injection, ... Read More
Dr. Reddy’s Labs rolls out Carmustine for Injection, USP in US
Dr. Reddy’s Laboratories (Dr. Reddy’s Labs), an Indian pharma company, has launched Carmustine for Injection, USP in the US in the form of a lyophilized ... Read More
Dr. Reddy’s launches Minoxidil for treatment of female pattern hair loss
Dr. Reddy's Laboratories said that it has launched a prescription drug for the treatment of female pattern hair loss (FPHL) in the form of Minoxidil ... Read More
Panacea Biotec supplies first shipment of Sputnik V second component produced in India
Panacea Biotec and the Russian Direct Investment Fund (RDIF) said that the former has supplied the first shipment of the second component of the Russian ... Read More
Dr. Reddy’s Labs signs deal worth up to $150m to sell E7777 rights to Citius
Dr. Reddy's Laboratories (Dr. Reddy's Labs) has agreed to divest its rights to E7777, an engineered IL-2-diphtheria toxin fusion protein, and certain related assets to ... Read More
Dr. Reddy’s Laboratories relaunches OTC Naproxen Sodium Tablets in US
Dr. Reddy’s Laboratories said that it has relaunched over-the-counter (OTC) Naproxen Sodium Tablets USP, 220 mg, the store-brand equivalent of Bayer HealthCare’s Aleve, in the ... Read More
Panacea Biotech to produce 25 million doses of Sputnik V corona vaccine
Indian vaccine producer Panacea Biotech has signed a licensing deal for producing 25 million doses of the Sputnik V corona vaccine. The company has entered ... Read More
Dr. Reddy’s Labs to sell certain rights for ELYXYB to BioDelivery Sciences
Dr. Reddy's Laboratories (Dr. Reddy's Labs) has agreed to divest its US and Canada rights for migraine drug — ELYXYB (celecoxib oral solution) 25 mg/ml, ... Read More
ICICI Lombard, Dr. Reddy’s partner to offer cashless outpatient services
ICICI Lombard General Insurance Company has entered into a partnership with SVAAS Wellness Limited, a fully-owned subsidiary of Dr. Reddy’s Laboratories Limited for launching a ... Read More